About us

Lipidor AB is a Swedish, Stockholm based, company developing topical products offering unique lipid based formulation opportunities across Pharma, Consumer Healthcare and Animal Care.

The company was established in 2009 by a team of researchers with vast experience in lipid technology, based on the idea to develop an innovative vehicle for dermatology applications. After feasibility had been confirmed and intellectual property covered, products in different dermatology areas are being developed and licensed out.

Research and development is conducted at Stockholm University and Karolinska Institutet Science Park in Stockholm, while GMP development and production for early stage and clinical trials are performed at our partners’ and shareholders’ sites at Cerbios-Pharma SA (Pharma) and Aurena Laboratories AB (Consumer Healthcare and Animal Health).

Our mission

To develop lipid based topical products improving patients quality of life.

Our vision

To establish AKVANO® as one of the preferred technologies for dermatological products.

 

Management

Ola Holmlund - CEO

CEO, Former Head of Sales at Kibion AB, Ola Holmlund has served in senior sales and business development roles in a wide range of technology and life science companies for more than 20 years, including Biolin Scientific AB, COSMED srl, and Aerocrine AB. He has a BSc in Business Administration from International University of Monaco, and is a Certified Coach with the COPA International Coaching Community.

Michael Owens - CFO

With a BSBA (Bachelor Business Administration in accounting and auditing Michael Owens has held executive finance positions in both the US and Sweden. From 2007 – 2012 he was Group Controller of Karolinska Development, playing a key role in successfully taking the company public in 2011. He has extensive executive experience in the medtech research field, guiding companies surely through a complex legislative and fiscal landscape.

Jan Holmbäck - CSO

PhD, Chief Scientific Officer Dr Holmbäck has more than 30 years of experience from the pharmaceutical industry in the fields of analytical and organic chemistry. He is specialized in the characterization of lipid materials, particularly by spectroscopic and chromatographic methods, and the use of lipids in drug delivery systems. Previous appointments include positions at Kabi, Pharmacia, and as Senior Scientist at LipoCore. Dr Holmbäck holds a PhD in Organic Chemistry from the Royal Institute of Technology, Stockholm. Co-founder.

Anders Hagman

Chief Development Officer, Anders Hagman holds a PhD and Master’s degree in Analytical Chemistry from Stockholm University. He has over 30 years of experience from leading positions and expert roles in the life science sector. For the past 10 years, he has worked as CDO and QC manager for Cobra Biologics.

 

Directors

Fredrik Sjövall

Chairman. CEO of Inhalation Sciences AB. Graduated from the Chalmers University of Technology (MSc). Previous appointments include CEO at PharmaSurgics and Lipopeptide (currently Promore Pharma). Sjövall has spent more than 10 years as the CEO of early stage companies in the life science industry.

Ola Flink

Pharmacist. Brings experience from more than 30 years in the pharmaceutical drug development industry.

Gunilla Lundmark

CEO of Uppsala University Holding Company AB. BSc and Executive MBA. Previous appointments include CEO for Pharmanest AB and vice president for Q-Med AB. Gunilla has 30 years of experience in the life science industry.

Otto Skolling

(Photo to follow).

Master’s degree in Chemical Engineering from the Royal Institute of Technology in Stockholm. Otto has 20 years of broad experience in the pharmaceutical and medical technology industries, including product development, business development and project management that he earned through leading positions at Novozymes, Siemens Life Support Systems and Pharmacia & Upjohn.

Denis Angioletti

(Photo to follow.)

University degree in pharmaceutical chemistry and engineering from Milan University. Denis has more than 20 years of experience in the pharmaceutical and bulk API industry in Europe.

Founders

Bengt Herslöf

PhD, Prof, Senior Scientific Advisor Dr Herslöf has over 40 years of experience working with lipid sciences in the areas of pharmaceuticals and food, including positions at Karlshamns AB and KabiVitrum AB. In 1986 he co-founded and was the CEO of LipidTeknik AB, which became LTP Lipid Technologies Provider AB in 2001, and was acquired by DSM in 2006. Dr Herslöf received his PhD in Organic Chemistry at Lund University, Sweden. Co-founder.

Anders Carlsson

PhD, Senior Advisor. Dr Carlsson has more than 30 years of industrial experience in pharmaceutical development, specializing within the fields of applied colloid and surface science, liquid and semi-solid pharmaceutical formulations, and drug delivery systems. He has vast experience of business development in the field. He is also active in his consultancy company MediGelium AB. AKVANO is based on an original idea by MediGelium. He has a PhD in Physical Chemistry from Lund University, Sweden. Co-founder.

Jan Holmbäck

PhD, Chief Scientific Officer Dr Holmbäck has more than 30 years of experience from the pharmaceutical industry in the fields of analytical and organic chemistry. He is specialized in the characterization of lipid materials, particularly by spectroscopic and chromatographic methods, and the use of lipids in drug delivery systems. Previous appointments include positions at Kabi, Pharmacia, and as Senior Scientist at LipoCore. Dr Holmbäck holds a PhD in Organic Chemistry from the Royal Institute of Technology, Stockholm. Co-founder.

Gerhard Miksche

PhD; Associate Prof. (Gothenburg University), Dr Miksche has extensive experience in pharmaceutical development and Intellectual Property Right management. Previous appointment include lecturer in Organic Chemistry, Lund University, Head of Chemical Dept., Workers Protection Agency 1976-77; Dept. Director (Pharmaceuticals and Medical Technology) at Swedish Governmental Board of Technological Development (STU) and Head of AB Astra Patent & TM Dept. Dr Miksche is currently active as Intellectual Property Consultant (Conimar AB & Inproc AB).
Co-founder.

Olle Holmertz

Business Controller Mr Holmertz has 15 years of experience from positions as CEO, CFO, Investor and Board member in technology companies (medical and other) and venture capital firms. Previous appointments include CFO of LTP Lipid Technologies Provider AB, and CIMON Medical AB. Mr Holmertz has an MSc in Business Administration and Economics from Lund University, Sweden. Co-founder.

Partners

Cerbios-Pharma SA: A Swiss API CDMO and API manufacturer, supplier of calcipotriol to Lipidor. Supplied clinical testing material to AKP01 Phase III study. Shareholder.

Aurena Laboratories AB: A Swedish Bag-on-Valve manufacturer, involved in co-development and manufacturing of animal care and consumer health care products. Shareholder.